MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Illumina Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

100.95 1.23

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

98.25

Max

102.08

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-262M

-131M

Pardavimai

18M

1.1B

P/E

Sektoriaus vid.

11.629

35.739

Pelno marža

-12.37

Darbuotojai

8,970

EBITDA

123M

399M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+12.06% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-03

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-3.3B

14B

Ankstesnė atidarymo kaina

99.72

Ankstesnė uždarymo kaina

100.95

Naujienos nuotaikos

By Acuity

15%

85%

19 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Illumina Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-03-11 09:18; UTC

Karštos akcijos

Stocks to Watch Tuesday: Tesla, Oracle, Delta, Nvidia -- WSJ

2025-03-10 21:07; UTC

Svarbiausios naujienos

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

2025-03-10 20:01; UTC

Svarbiausios naujienos

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

2025-03-04 10:56; UTC

Karštos akcijos

Stocks to Watch Tuesday: Illumina, Nvidia, Stellantis -- WSJ

Akcijų palyginimas

Kainos pokytis

Illumina Inc Prognozė

Kainos tikslas

By TipRanks

12.06% į viršų

12 mėnesių prognozė

Vidutinis 114.59 USD  12.06%

Aukščiausias 185 USD

Žemiausias 75 USD

Remiantis 18 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Illumina Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

18 ratings

7

Pirkti

8

Laikyti

3

Parduoti

Techninis įvertinimas

By Trading Central

77.61 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

19 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat